|
It has been interesting to read that Malaria and HIV treatments seem to be showing signs of effective treatment. Both are blood "issues" and not lung "issues". Read one piece that equated the effect of C19 to carbon monoxide in that C19 may be impacting the hemoglobin ability to carry Oxygn. All very anecdotal at this point, but each day you here some additional confirmatory rumblings.
Here is the official Gilead statement on Remdesivir:
Remdesivir is an investigational nucleotide analog with broad-spectrum antiviral activity – it is not approved anywhere globally for any use. Remdesivir has demonstrated in vitro and in vivo activity in animal models against the viral pathogens MERS and SARS, which are also coronaviruses and are structurally similar to COVID-19. The limited preclinical data on remdesivir in MERS and SARS indicate that remdesivir may have potential activity against COVID-19.
Remdesivir is an experimental medicine that does not have established safety or efficacy for the treatment of any condition.
|